phosphorylcholine has been researched along with Leukocytosis in 5 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
Leukocytosis: A transient increase in the number of leukocytes in a body fluid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "34 patients with metastatic colorectal cancer were treated with the ether lipid miltefosine (hexadecylphosphocholine)." | 9.07 | Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancer. ( Planting, AS; Stoter, G; Verweij, J, 1993) |
| " Perifosine is a novel alkyl-lysophospholipid that can induce apoptosis in multiple myeloma (MM) tumor cells, both in vitro and in vivo." | 7.74 | Alkyl phospholipid perifosine induces myeloid hyperplasia in a murine myeloma model. ( Anderson, KC; Bronson, R; Catley, L; Chauhan, D; Hideshima, T; Munshi, NC; Neri, P; Song, W; Tai, YT; Tassone, P, 2007) |
| "34 patients with metastatic colorectal cancer were treated with the ether lipid miltefosine (hexadecylphosphocholine)." | 5.07 | Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancer. ( Planting, AS; Stoter, G; Verweij, J, 1993) |
| " Perifosine is a novel alkyl-lysophospholipid that can induce apoptosis in multiple myeloma (MM) tumor cells, both in vitro and in vivo." | 3.74 | Alkyl phospholipid perifosine induces myeloid hyperplasia in a murine myeloma model. ( Anderson, KC; Bronson, R; Catley, L; Chauhan, D; Hideshima, T; Munshi, NC; Neri, P; Song, W; Tai, YT; Tassone, P, 2007) |
| " In addition, at the highest dosage group in rats, an increase in white blood cell counts (WBC) was observed." | 2.67 | Increases in leucocyte and platelet counts induced by the alkyl phospholipid hexadecylphosphocholine. ( Drogendijk, TE; Oosterom, R; Planting, AS; Pronk, LC; Stoter, G; Verweij, J, 1994) |
| " A dose-response relationship was seen after daily oral treatment with complete suppression of tumor growth at doses of 46." | 1.27 | Characterization of the antitumor activity of hexadecylphosphocholine (D 18506). ( Berger, MR; Eibl, H; Engel, J; Hilgard, P; Schumacher, W; Stekar, J; Unger, C; Voegeli, R, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catley, L | 1 |
| Hideshima, T | 1 |
| Chauhan, D | 1 |
| Neri, P | 1 |
| Tassone, P | 1 |
| Bronson, R | 1 |
| Song, W | 1 |
| Tai, YT | 1 |
| Munshi, NC | 1 |
| Anderson, KC | 1 |
| Pronk, LC | 1 |
| Planting, AS | 2 |
| Oosterom, R | 1 |
| Drogendijk, TE | 1 |
| Stoter, G | 2 |
| Verweij, J | 2 |
| Murray, SE | 1 |
| Lallman, HR | 1 |
| Heard, AD | 1 |
| Rittenberg, MB | 1 |
| Stenzel-Poore, MP | 1 |
| Hilgard, P | 1 |
| Stekar, J | 1 |
| Voegeli, R | 1 |
| Engel, J | 1 |
| Schumacher, W | 1 |
| Eibl, H | 1 |
| Unger, C | 1 |
| Berger, MR | 1 |
2 trials available for phosphorylcholine and Leukocytosis
| Article | Year |
|---|---|
Increases in leucocyte and platelet counts induced by the alkyl phospholipid hexadecylphosphocholine.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, | 1994 |
Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Female; Humans; Leuk | 1993 |
3 other studies available for phosphorylcholine and Leukocytosis
| Article | Year |
|---|---|
Alkyl phospholipid perifosine induces myeloid hyperplasia in a murine myeloma model.
Topics: Animals; Apoptosis; Cell Line; Female; Hematopoiesis; Humans; Hyperplasia; Leukocytosis; Mice; Multi | 2007 |
A genetic model of stress displays decreased lymphocytes and impaired antibody responses without altered susceptibility to Streptococcus pneumoniae.
Topics: Animals; Antibody Formation; B-Lymphocytes; Genetic Predisposition to Disease; Hemocyanins; Injectio | 2001 |
Characterization of the antitumor activity of hexadecylphosphocholine (D 18506).
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Benzopyrenes; Choline; Cyclophosphamide; Dose-Response Re | 1988 |